BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23373681)

  • 1. A known-groups evaluation of the response bias scale in a neuropsychological setting.
    Sullivan KA; Elliott CD; Lange RT; Anderson DS
    Appl Neuropsychol Adult; 2013; 20(1):20-32. PubMed ID: 23373681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of the validity of the MMPI-2 response bias scale using an analog simulation design.
    Sullivan KA; Elliott C
    Clin Neuropsychol; 2012; 26(1):160-76. PubMed ID: 22263855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of MMPI-2 validity scale scores of personal injury litigants and disability claimants.
    Tsushima WT; Geling O; Fabrigas J
    Clin Neuropsychol; 2011 Nov; 25(8):1403-14. PubMed ID: 22003896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scores on the MMPI-2-RF scales as a function of increasing levels of failure on cognitive symptom validity tests in a military sample.
    Jones A; Ingram MV; Ben-Porath YS
    Clin Neuropsychol; 2012; 26(5):790-815. PubMed ID: 22709365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the response bias scale (RBS) and other MMPI-2 validity scales in predicting TOMM performance.
    Whitney KA; Davis JJ; Shepard PH; Herman SM
    Arch Clin Neuropsychol; 2008; 23(7-8):777-86. PubMed ID: 18930375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the MMPI-2 Response Bias Scale and Henry-Heilbronner Index in a U.S. veteran population.
    Young JC; Kearns LA; Roper BL
    Arch Clin Neuropsychol; 2011 Apr; 26(3):194-204. PubMed ID: 21459900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a Response Bias Scale (RBS) for the MMPI-2.
    Gervais RO; Ben-Porath YS; Wygant DB; Green P
    Assessment; 2007 Jun; 14(2):196-208. PubMed ID: 17504891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting test of memory malingering and medical symptom validity test failure within a Veterans Affairs Medical Center: use of the Response Bias Scale and the Henry-Heilbronner Index.
    Whitney KA
    Arch Clin Neuropsychol; 2013 May; 28(3):222-35. PubMed ID: 23493404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and specificity of MMPI-2 validity scales and indicators to malingered neurocognitive dysfunction in traumatic brain injury.
    Greve KW; Bianchini KJ; Love JM; Brennan A; Heinly MT
    Clin Neuropsychol; 2006 Sep; 20(3):491-512. PubMed ID: 16895861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting negative response bias with the Fake Bad Scale, Response Bias Scale, and Henry-Heilbronner Index of the Minnesota Multiphasic Personality Inventory-2.
    Dionysus KE; Denney RL; Halfaker DA
    Arch Clin Neuropsychol; 2011 Mar; 26(2):81-8. PubMed ID: 21148668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in MMPI-2 FBS and RBS scores in brain injury, probable malingering, and conversion disorder groups: a preliminary study.
    Peck CP; Schroeder RW; Heinrichs RJ; Vondran EJ; Brockman CJ; Webster BK; Baade LE
    Clin Neuropsychol; 2013; 27(4):693-707. PubMed ID: 23510271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the MMPI-2-RF and PAI overreporting indicators in a civil forensic sample with emphasis on the Response Bias Scale (RBS) and the Cognitive Bias Scale (CBS).
    Tylicki JL; Rai JK; Arends P; Gervais RO; Ben-Porath YS
    Psychol Assess; 2021 Jan; 33(1):71-83. PubMed ID: 33090826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental validity of the MMPI-2-RF over-reporting scales and RBS in assessing the veracity of memory complaints.
    Gervais RO; Ben-Porath YS; Wygant DB; Sellbom M
    Arch Clin Neuropsychol; 2010 Jun; 25(4):274-84. PubMed ID: 20335183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting malingering in traumatic brain injury and chronic pain with an abbreviated version of the Meyers Index for the MMPI-2.
    Aguerrevere LE; Greve KW; Bianchini KJ; Meyers JE
    Arch Clin Neuropsychol; 2008; 23(7-8):831-8. PubMed ID: 18715751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of the new MMPI-2 Response Bias Scale (Gervais): relationship with MMPI-2 validity scales.
    Nelson NW; Sweet JJ; Heilbronner RL
    J Clin Exp Neuropsychol; 2007 Jan; 29(1):67-72. PubMed ID: 17162723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of response bias and noncredible performance in adult attention-deficit/hyperactivity disorder.
    Young JC; Gross AM
    Arch Clin Neuropsychol; 2011 Apr; 26(3):165-75. PubMed ID: 21441258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of selected MMPI-2 and MMPI-2-RF validity scales in assessing effort on cognitive tests in a military sample.
    Jones A; Ingram MV
    Clin Neuropsychol; 2011 Oct; 25(7):1207-27. PubMed ID: 21902565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does True Neurocognitive Dysfunction Contribute to Minnesota Multiphasic Personality Inventory-2nd Edition-Restructured Form Cognitive Validity Scale Scores?
    Martin PK; Schroeder RW; Heinrichs RJ; Baade LE
    Arch Clin Neuropsychol; 2015 Aug; 30(5):377-86. PubMed ID: 26051870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of MMPI-2-RF validity scales in criterion group neuropsychological samples.
    Schroeder RW; Baade LE; Peck CP; VonDran EJ; Brockman CJ; Webster BK; Heinrichs RJ
    Clin Neuropsychol; 2012; 26(1):129-46. PubMed ID: 22150551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential sensitivity of the Response Bias Scale (RBS) and MMPI-2 validity scales to memory complaints.
    Gervais RO; Ben-Porath YS; Wygant DB; Green P
    Clin Neuropsychol; 2008 Dec; 22(6):1061-79. PubMed ID: 18609315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.